Mettler-Toledo International (NYSE:MTD) Price Target Raised to $1,350.00

Mettler-Toledo International (NYSE:MTD) had its target price raised by Barclays from $1,325.00 to $1,350.00 in a research note published on Thursday morning,Benzinga reports. The firm currently has an overweight rating on the medical instruments supplier’s stock.

A number of other research analysts have also recently issued reports on MTD. Evercore ISI decreased their price target on shares of Mettler-Toledo International from $1,280.00 to $1,275.00 and set an “outperform” rating for the company in a report on Monday, August 4th. Robert W. Baird raised their target price on Mettler-Toledo International from $1,210.00 to $1,230.00 and gave the stock a “neutral” rating in a research note on Monday, August 4th. Citigroup boosted their price target on Mettler-Toledo International from $1,400.00 to $1,600.00 and gave the company a “buy” rating in a research note on Thursday, August 21st. Finally, Bank of America raised their price objective on Mettler-Toledo International from $1,260.00 to $1,390.00 and gave the stock a “neutral” rating in a research note on Monday, September 22nd. Five investment analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. According to MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $1,328.33.

Mettler-Toledo International Price Performance

Shares of NYSE:MTD opened at $1,314.48 on Thursday. The business’s 50-day moving average is $1,272.23 and its 200 day moving average is $1,186.11. Mettler-Toledo International has a 1 year low of $946.69 and a 1 year high of $1,486.76. The firm has a market capitalization of $27.08 billion, a P/E ratio of 33.29, a P/E/G ratio of 3.94 and a beta of 1.37.

Mettler-Toledo International (NYSE:MTD) last issued its quarterly earnings results on Thursday, July 31st. The medical instruments supplier reported $10.09 earnings per share for the quarter, topping analysts’ consensus estimates of $9.58 by $0.51. The business had revenue of $983.22 million for the quarter, compared to analyst estimates of $957.41 million. Mettler-Toledo International had a negative return on equity of 476.07% and a net margin of 21.46%.The company’s revenue was up 3.9% on a year-over-year basis. During the same quarter in the previous year, the firm earned $9.65 earnings per share. Mettler-Toledo International has set its FY 2025 guidance at 42.100-42.600 EPS. Q3 2025 guidance at 10.550-10.750 EPS. On average, analysts expect that Mettler-Toledo International will post 42.71 EPS for the current year.

Insider Buying and Selling

In other news, insider Gerry Keller sold 165 shares of the firm’s stock in a transaction that occurred on Thursday, August 14th. The stock was sold at an average price of $1,308.64, for a total value of $215,925.60. Following the transaction, the insider owned 94 shares in the company, valued at $123,012.16. This trade represents a 63.71% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Thomas P. Salice sold 1,062 shares of the business’s stock in a transaction dated Wednesday, August 13th. The shares were sold at an average price of $1,300.90, for a total transaction of $1,381,555.80. Following the completion of the transaction, the director owned 283 shares in the company, valued at $368,154.70. The trade was a 78.96% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 1,827 shares of company stock valued at $2,371,208. 1.94% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the business. WPG Advisers LLC acquired a new stake in Mettler-Toledo International during the first quarter worth $41,000. NewSquare Capital LLC grew its holdings in shares of Mettler-Toledo International by 94.4% during the 2nd quarter. NewSquare Capital LLC now owns 35 shares of the medical instruments supplier’s stock worth $41,000 after purchasing an additional 17 shares during the period. MV Capital Management Inc. increased its position in shares of Mettler-Toledo International by 50.0% during the 2nd quarter. MV Capital Management Inc. now owns 36 shares of the medical instruments supplier’s stock worth $42,000 after purchasing an additional 12 shares during the last quarter. Zions Bancorporation National Association UT purchased a new stake in Mettler-Toledo International in the 1st quarter valued at about $43,000. Finally, Golden State Wealth Management LLC lifted its position in Mettler-Toledo International by 583.3% in the first quarter. Golden State Wealth Management LLC now owns 41 shares of the medical instruments supplier’s stock valued at $48,000 after buying an additional 35 shares during the last quarter. 95.07% of the stock is currently owned by institutional investors and hedge funds.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.